All News about NGM Biopharmaceuticals, Inc. - Common Stock









Via Benzinga






NGM Bio To Highlight Updated Preliminary Findings From Advanced Solid Tumors Trial
September 06, 2022
Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
October 18, 2022
Via Benzinga













Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.